|Bid||25.64 x 1800|
|Ask||0.00 x 800|
|Day's range||25.83 - 26.16|
|52-week range||25.83 - 28.30|
|Beta (5Y monthly)||1.28|
|PE ratio (TTM)||4.36|
|Forward dividend & yield||1.41 (5.36%)|
|Ex-dividend date||29 Nov 2021|
|1y target est||N/A|
Ladies and gentlemen, we would like to thank you for standing by and welcome to the MetLife Third Quarter 2021 Earnings Release Conference Call. Before we get started, I would refer you to the cautionary note about forward-looking statements in yesterday's earnings release and to risk factors discussed in MetLife's SEC filings. With that, I will turn the call over to John Hall, Global Head of Investor Relations.
MetLife's (MET) Q3 earnings gain from better revenues and solid performances by its EMEA, Asia, and MetLife Holdings segments.
“Variable investment income was considerably above, COVID-related claims were significantly worse, making for a noisy quarter. Underlying the noise – core results were solid, matching our expectations, augmented by aggressive capital management,” noted Nigel Dally, equity analyst at Morgan Stanley.